Nav: Home

Liquid meal replacements contributed to greater weight loss than low-calorie diets: review

March 28, 2019

Liquid meal replacements helped overweight diabetes patients lose an average of about five pounds more than others who tried a conventional low-calorie diet, according to a meta-analysis of randomized controlled trials.

The analysis, which was commissioned by the European Association for the Study of Diabetes, compared outcomes of patients on various diets after 24 weeks and also found liquid meal replacements contributed to better reductions of body mass index and systolic blood pressure.

The review is published in Diabetes Care, a journal of the American Diabetes Association.

"This study suggests there's one more tool for patients with diabetes to help them meet their weight-loss goals," said lead author Dr. John Sievenpiper of Toronto's St. Michael's Hospital.

"This is another way to achieve weight-loss goals but I'd emphasize there is no best way. The method that's superior is the one the individual themselves is able to follow and sustain."

The median estimated dose of liquid meal replacement being used by patients represented about 20 percent of their total energy intake. This review suggests the use of liquid meal replacements within a structured dietary plan may offer a viable solution when replacing one or two meals each day and supplemented with fruits, vegetables and nuts to achieve a targeted daily caloric intake.

"I think liquid meal replacements could be a way to get to weight loss and then work on achieving a healthier diet to maintain that weight loss," said Dr. Sievenpiper, who is also a scientist with the hospital's Li Ka Shing Knowledge Institute and the Clinical Nutrition and Risk Modification Centre.

The review also analyzed how liquid meal replacements performed in randomized controlled trials for other factors such as body fat, waist circumference and diastolic blood pressure but only marginal clinical significance was observed.
-end-
Disclosures:

This research was funded in part by the Diabetes and Nutrition Study Group of the European Association of the Study of Diabetes, the Canadian Institutes of Health Research through the Canada-wide Human Nutrition Trialists' Network, and the Diet, Digestive tract, and Disease (3-D) Centre through the Canada Foundation for Innovation and the Ministry of Research and Innovation's Ontario Research Fund.

Dr. Sievenpiper has previously received research funding or travel or consulting fees from a number of food companies including Abbott Nutrition and Nestle, which both produce liquid meal replacements. They were not involved in this research. A full list of disclosures is listed within the article.

About St. Michael's Hospital and Unity Health Toronto:

Unity Health Toronto, comprised of Providence Healthcare, St. Joseph's Health Centre and St. Michael's Hospital, works to advance the health of everyone in our urban communities and beyond. Our health network serves patients, residents and clients across the full spectrum of care, spanning primary care, secondary community care, tertiary and quaternary care services to post-acute through rehabilitation, palliative care and long-term care, while investing in world-class research and education. For more information, visit http://www.unityhealth.to.

St. Michael's Hospital

Related Diabetes Articles:

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.